AAAAAA
Results: 1-25/31
Authors:
TKACZUK K
BROOKS S
MINFORD J
MEISENBERG B
FEDENKO K
SIVASAILAM S
TAIT N
VANECHO D
Citation: K. Tkaczuk et al., PHASE-I TRIAL OF DOCETAXEL (DOTAX) AND TOPOTECAN HYDROCHLORIDE (TOPO)IN PATIENTS WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 641-641
Authors:
MEISENBERG B
BREHM T
SCHMECKEL A
MILLER W
MCMILLAN R
Citation: B. Meisenberg et al., A COMBINATION OF LOW-DOSE CYCLOPHOSPHAMIDE AND COLONY-STIMULATING FACTORS IS MORE COST-EFFECTIVE THAN GRANULOCYTE-COLONY-STIMULATING FACTORS ALONE IN MOBILIZING PERIPHERAL-BLOOD STEM AND PROGENITOR CELLS, Transfusion, 38(2), 1998, pp. 209-215
Authors:
ELKORDY M
CRUMP M
VREDENBURGH JJ
PETROS WP
HUSSEIN A
RUBIN P
ROSS M
GILBERT C
MODLIN C
MEISENBERG B
CONIGLIO D
RABINOWITZ J
LAUGHLIN M
KURTZBERG J
PETERS WP
Citation: M. Elkordy et al., A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (OCT-43) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(4), 1997, pp. 315-322
Authors:
MEISENBERG B
GOLLARD R
BREHM T
MCMILLAN R
MILLER W
Citation: B. Meisenberg et al., PROPHYLACTIC ANTIBIOTICS ELIMINATE BACTEREMIA AND ALLOW SAFE OUTPATIENT MANAGEMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL RESCUE, Supportive care in cancer, 4(5), 1996, pp. 364-369
Authors:
MEISENBERG B
MCKEE D
Citation: B. Meisenberg et D. Mckee, PNEUMOCYSTIS-CARINII PNEUMONIA (PCP) FOLLOWING TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PBPC SUPPORT, Bone marrow transplantation, 18(4), 1996, pp. 823-823
Authors:
MEISENBERG B
Citation: B. Meisenberg, HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT FOR PATIENTS WITH MALIGNANT-MELANOMA, Bone marrow transplantation, 17(6), 1996, pp. 903-906
Authors:
MEISENBERG B
FRAKES L
BREHM T
SHMECKEL A
MILLER W
MCMILLAN R
Citation: B. Meisenberg et al., SINGLE LARGE-VOLUME LEUKAPHERESIS (LVL) AFTER MOBILIZATION WITH LOW-DOSE CYCLOPHOSPHAMIDE, GM-CSF AND G-CSF ALLOWS PREDICTABLE AND SUCCESSFUL COLLECTION OF STEM-CELLS, Blood, 88(10), 1996, pp. 3684-3684
Authors:
FRAKES L
MILLER W
MCMILLAN R
MEISENBERG B
Citation: L. Frakes et al., HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (HDC PBSCT) FOR MANTLE CELL LYMPHOMA (MCL)/, Blood, 88(10), 1996, pp. 3859-3859
Authors:
MEISENBERG B
FRAKES L
BREHM T
SCHMECKEL A
MILLER W
MCMILIAN R
Citation: B. Meisenberg et al., USE OF G-CSF GIVEN TO ALLOGENEIC DONORS TO IMPROVE CD34 YIELDS IN BONE-MARROW COLLECTIONS AND HASTEN ENGRAFTMENT, Blood, 88(10), 1996, pp. 1599-1599
Authors:
ELLIS GK
HUTCHINS L
JIMENEZMARTIN M
PECORA AL
BARNADAS A
MEISENBERG B
NABHOLTZ JM
CORTESFUNES H
RIFKIN R
CHANG AYC
GARRISON L
GEORGE C
GILES FJ
Citation: Gk. Ellis et al., PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA, Blood, 88(10), 1996, pp. 1783-1783
Authors:
HUSSEIN AM
ROSS M
VREDENBURGH J
MEISENBERG B
HARS V
GILBERT C
PETROS WP
CONIGLIO D
KURTZBERG J
RUBIN P
PETERS WP
Citation: Am. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, European journal of haematology, 54(5), 1995, pp. 281-287
Authors:
MEISENBERG B
Citation: B. Meisenberg, TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(25), 1995, pp. 1718-1718
Authors:
GOLLARD R
MEISENBERG B
MCMILLAN R
MILLER W
Citation: R. Gollard et al., PROPHYLACTIC ANTIBIOTICS (PRABX) IN PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTS - VIRTUAL ELIMINATION OF BACTEREMIA ALLOWS OUTPATIENT MANAGEMENT, Blood, 86(10), 1995, pp. 839-839
Authors:
MEISENBERG B
MILLER W
MCMILLAN R
PIRO L
Citation: B. Meisenberg et al., NEAR-TOTAL OUTPATIENT TRANSPLANTS (NTOT) - ACCUMULATED EXPERIENCE IN 125 TRANSPLANTS WITH A FINANCIAL ANALYSIS ON A SUBSET OF PATIENTS (PTS), Blood, 86(10), 1995, pp. 840-840
Authors:
MEISENBERG B
MILLER W
MCMILLAN R
Citation: B. Meisenberg et al., LOWER DOSE CYCLOPHOSPHAMIDE (LDC) PLUS GROWTH-FACTOR (GF) RESULTS IN EFFICIENT AND PREDICTABLE MOBILIZATION (MZ) OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC), Blood, 86(10), 1995, pp. 9341-9341
Authors:
TONER GC
GABRILOVE JL
GORDON M
CROWN J
JAKUBOWSKI AA
MEISENBERG B
SHERIDAN C
BOONE T
VINCENT ME
MARKMAN M
Citation: Gc. Toner et al., PHASE-I TRIAL OF INTRAVENOUS AND INTRAPERITONEAL ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 59-66
Authors:
GILBERT C
MEISENBERG B
VREDENBURGH J
ROSS M
HUSSEIN A
PERFECT J
PETERS WP
Citation: C. Gilbert et al., SEQUENTIAL PROPHYLACTIC ORAL AND EMPIRIC ONCE-DAILY PARENTERAL ANTIBIOTICS FOR NEUTROPENIA AND FEVER AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, Journal of clinical oncology, 12(5), 1994, pp. 1005-1011
Authors:
MEISENBERG B
Citation: B. Meisenberg, ETOPOSIDE FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 12(10), 1994, pp. 2235-2235
Authors:
NEMUNAITIS J
ROSS M
MEISENBERG B
APPELBAUM FR
BUHLES W
SINGER J
PETERS WP
OREILLY R
LILLEBY K
BUCKNER CD
Citation: J. Nemunaitis et al., PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA (RHIL-1-BETA) IN PATIENTS WITH BONE-MARROW FAILURE, Bone marrow transplantation, 14(4), 1994, pp. 583-588
Authors:
MEISENBERG B
LASSITER M
HUSSEIN A
ROSS M
VREDENBURGH JJ
PETERS WP
Citation: B. Meisenberg et al., PREVENTION OF HEMORRHAGIC CYSTITIS AFTER HIGH-DOSE ALKYLATING AGENT CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, Bone marrow transplantation, 14(2), 1994, pp. 287-291
Authors:
MUDAD R
VREDENBURGH J
PAULSON EK
ROSS M
MEISENBERG B
HUSSEIN A
PETERS WP
Citation: R. Mudad et al., A RADIOLOGIC SYNDROME AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, WITH CLINICAL AND PATHOLOGICAL FEATURES OF SYSTEMIC CANDIDIASIS, Cancer, 74(4), 1994, pp. 1360-1366
Authors:
VREDENBURGH J
WATERSPICK B
DRAGO S
AFFRONTI ML
KURTZBERG J
ROSS M
HUSSEIN A
RUBIN P
ELKORDY M
MEISENBERG B
PETERS WP
Citation: J. Vredenburgh et al., G-CSF-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) COLLECTED IN THE STEADY-STATE ARE SUPERIOR TO G-CSF-PRIMED PBPCS COLLECTED ON THE REBOUND FROM CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000107-10000107
Authors:
MEISENBERG B
MCMILLAN R
MILLER W
PIRO L
Citation: B. Meisenberg et al., HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN THE OUTPATIENT (OPC) CLINIC, Blood, 84(10), 1994, pp. 10000203-10000203
Authors:
MEISENBERG B
MCMILLAN R
MILLER W
Citation: B. Meisenberg et al., TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT - POTENTIAL FOR DELAYED ENGRAFTMENT AFTER THE 2ND CYCLE, Blood, 84(10), 1994, pp. 10000715-10000715
Authors:
MEISENBERG B
MILLER W
MCMILLAN R
Citation: B. Meisenberg et al., TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) SUPPORTED WITH G-CSF PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC), Blood, 84(10), 1994, pp. 10000715-10000715